My research group is interested in development and dissemination of new strategies to assess cancer risk, detect cancer at its early stages, develop and validate interventions to delay or reverse carcinogenesis progression. Using a global platform, we are able to understand differences in genetic and environmental risk in diverse populations and ultimately customize risk assessment tools, cancer detection biomarkers, and cancer risk reductive interventions.
Dean Brenner, MD
Moshe Talpaz M.D. Professor of Translational Oncology
Professor of Internal Medicine
Professor of Pharmacology
Countries of Interest: Israel, India, United Kingdom, Canada, Australia